Nascence

We are an early-stage biotechnology startup developing a novel rapid non-destructive cell culture platform that is easy to use, doesn’t contain animal product, and has a release time significantly quicker than the nearest competitor. This patent-pending technology is based on nearly a decade of scientific research and aimed at customers in research or clinical test settings where they need increasing yields of human cells (from biopsy or otherwise) that are highly sensitive to the chemicals and rough treatment.